Figures & data
Figure 1. Overall survival in MBC patients (bottom line) and FBC patients (top line). MBC patients have a significantly worse overall survival at five years follow-up compared with FBC patients (p = 0.001). After five years results are uncertain due to few patients at risk.
![Figure 1. Overall survival in MBC patients (bottom line) and FBC patients (top line). MBC patients have a significantly worse overall survival at five years follow-up compared with FBC patients (p = 0.001). After five years results are uncertain due to few patients at risk.](/cms/asset/8693e960-f3b4-4820-a3e0-2896ffec1e21/ionc_a_602114_f0001_b.gif)
Figure 2. Relative survival of MBC patients (bottom line) compared with FBC patients (top line). MBC patients have a significantly poorer relative survival at five years follow-up compared with FBC (p = 0.015). After five years results are uncertain due to few patients at risk.
![Figure 2. Relative survival of MBC patients (bottom line) compared with FBC patients (top line). MBC patients have a significantly poorer relative survival at five years follow-up compared with FBC (p = 0.015). After five years results are uncertain due to few patients at risk.](/cms/asset/698c06d0-2952-4a77-9777-77972461c08d/ionc_a_602114_f0002_b.gif)
Table I. Stage at diagnosis- MBC vs. FBC.
Table II. Histopathological characteristics- MBC vs. FBC.
Table III. Adjuvant treatment- MBC vs. FBC.